Post Partum Haemorrhage Clinical Trial
Official title:
Longitudinal Clinical, Controlled, Randomized, Open-label, Phase III Study to Assess the Equivalence of Tranexamic Acid (TXA) vs Oxytocin (OXY) in Reducing Post Partum Haemorrhage (PPH) in Patients at the End of Pregnancy (37-42 w), at Low Risk of PPH
The purpose of this study was to evaluate that the tranexamic acid (TXA)Intravenous and oral, is equivalent oxytocin (OXY),intramuscularly, in reducing the blood loss in post partum period (mL) in patients at the end of pregnancy ( 37-42 w ) at low risk of post partum hemorrhage (PPH). The PPH means a blood loss equal to or greater than 500 ml after a vaginal delivery (the bleeding is defined severe if it exceeds 1000 mL). PPH is called "primary" when blood loss arose within 24 hours after birth.
This trial includes three arms of treatment : - arm A (IMP1Test): TXA 500 mg/ 2 vials (1 gr) slow intravenous infusion 1ml/min within 5 minutes from the delivery(third stage af labor) - arm B (IMP2Control): OXY 5 IU/ml/ 2 vials (10 International Unit) intramuscularly within 5 minutes from the delivery (third stage af labor) The clamping of the umbilical cord will be executed immediately after birth. The randomization 1:1 (block design), generated by the computer. Primary outcomes: assessment of total blood loss expressed in mL: - immediately after delivery - two hours after delivery The measurement of the overall blood loss at delivery (ml) will be performed by the graduated bag, immediately after birth. The measurement two hours after delivery will be performed by weighing of the adsorbent material [ N.ml = N. gr indicated by the balance - dry weight of the sanitary napkin]. The overall loss in blood measured (ml) two hours of delivery will then be performed by adding the two collections. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02303418 -
Carbetocin Versus Oxytocin in the Prevention of Post Partum Haemorrhage (PPH) in Women Undergoing Caesarean Sections for Placenta Previa: A Randomised Controlled Trial
|
Phase 3 | |
| Recruiting |
NCT00344929 -
Severe Post Partum Haemorrhage (PPH): A Randomized Trial on Transversal Intervention in 6 French Perinatal Networks
|
N/A | |
| Not yet recruiting |
NCT05336838 -
Improving Management of Post-partum Haemorrhage With Quantra® System
|
||
| Completed |
NCT02216383 -
Intramuscular Oxytocics: A Randomised Control Trial
|
Phase 3 | |
| Completed |
NCT01571323 -
Combined Use of Oxytocin and Misoprostol Versus Oxytocin Infusion and Misoprostol Alone to Reduce Blood Loss at Cesarean Section
|
Phase 1/Phase 2 | |
| Terminated |
NCT02908126 -
Compare Efficacy of Oxytocin Administrations on Postpartum Uterine Contractility
|
Phase 1 | |
| Terminated |
NCT02900690 -
Health Economics Evaluation of the Management of Severe Postpartum Hemorrhage: Comparison of Recombinant Activated Factor VII Strategy to the Reference Strategy
|